Drug Design Methodologies, L.L.C.

Biotechnology company · Saint Louis, Missouri, United States

Drug Design Methodologies, L.L.C. is a biotechnology company headquartered in Saint Louis, Missouri, United States. It has received 2 US government small-business research awards (SBIR/STTR) from health agencies, $255,544 in total, most recently in 2018.

www.newdrugdesign.comProfile compiled from public records. Is this your company? Request a correction or update

Drug Design Methodologies at a glance

Typebiotechnology company

HeadquartersSaint Louis, Missouri, United States

Employees (self-reported, 2018)1

What does Drug Design Methodologies do?

US government research funding

2 SBIR/STTR small-business research awards from US health agencies, $255,544 in total (2000 to 2018). NIH funding came from the National Institute of General Medical Sciences.

Frequently asked questions about Drug Design Methodologies

Where is Drug Design Methodologies headquartered?

Drug Design Methodologies, L.L.C. is headquartered in Saint Louis, Missouri, United States.

What does Drug Design Methodologies do?

Drug Design Methodologies, L.L.C. is a biotechnology company.

Similar companies

MediBeacon Inc.St. Louis, Missouri, United States
C2N Diagnostics, LLCSt. Louis, Missouri, United States
Pulse Therapeutics, Inc.St. Louis, Missouri, United States
Panome Bio Inc.St. Louis, Missouri, United States
Cardialen, Inc.St. Louis, Missouri, United States
Gateway Biotechnology, Inc.St. Louis, Missouri, United States
Confluence Life Sciences, Inc.St. Louis, Missouri, United States
BacterioScan, Inc.St. Louis, Missouri, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences